Follow RSS for latest reports on this topicAcute Coronary Syndromes ACS - Market Research and Reports

Acute Coronary Syndromes (ACS) is an umbrella term for situations where the blood supplied to the heart muscle is suddenly blocked. Treatment for acute coronary syndrome includes medicines and a procedure known as angioplasty, during which doctors inflate a small balloon to open the artery.  A stent, a wire mesh tube, may be permanently placed in the artery to keep it open.

See also BioPortfoli's Stent Twitter account -

BioPortfolio's Easy Ordering System

  1. Search for the report you need from our store
  2. Make online payment with our easy checkout process
  3. Receive PDF report via email

Easy Online Payment or Pro Forma Invoice

We accept the following credit cards...

or can supply a pro-forma invoice if required.

Related Reports:

We found over 40 reports that matched your search.

Next 40 Matches >

Refine your search, and find more matches, using the form above.

Global Cardiac Biomarkers Market Size study, by type (Myocardial muscle Creatine Kinase, Myoglobin, Troponins (T and I), Ischemia Modified Albumin (IMA), Brain Natriuretic Peptide (BNPs) or NT-proBNP and Others) Application (myocardial infarction, congestive heart failure, acute coronary syndrome, Atherosclerosis, other applications) Location of Testing (point of care testing and laboratory testin

Global cardiac biomarkers market to reach USD 4,957.1 million by 2025.Global cardiac biomarkers market is valued at approximately USD 1,241 million in 2017 and is anticipated to grow with a healthy growth rate of more than 18.9 % over the forecast period 2018-2025. Rising prevalence of cardiovascular diseases cost effective device, non-invasive method, accuracy in prediction, helpful in clinical t...Read More >>>


Published by: Bizwit Research and Consulting

Prices Starting From:

Additional Searches

You may also like to search separately for: Acute Coronary Syndromes ACS

We Stock...